NewAmsterdam Pharma
Developing transformative, clinically validated oral therapies for patients with metabolic diseases.
Launch date
Employees
Market cap
€1.3b
Enterprise valuation
€918m (Public information from Sep 2024)
Share price
$16.06 NAMS
Naarden North Holland (HQ)
Authorizing premium user...